All stock lists
PACS Group, Inc. (New York Stock Exchange:PACS)
US · Delayed Price · Currency is USD
47.64+0.14 (+0.29%)
Insider Score
––Not scored
PACS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
PACS analyst forecast
PACS analyst consensus
Moderate Buy5 ratings
Buy 5 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
PACS 12-month price target
$62.00+25.7% upsideaverage of 1 firm
$62.00High
$62.00Low
Best analysts covering PACS
- Truist Securities20%success rate · 5 calls
- Oppenheimer0%success rate · 2 calls
- RBC Capital0%success rate · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
PACS analyst ratings
| Analyst | Firm | Rating | Price target | Upside | Action | Date |
|---|---|---|---|---|---|---|
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-09-04 |
| Truist Financial | — | $62.00 | +44.2% | — | 2026-09-02 | |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-08-10 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-08-06 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-08-06 |
| — | UBS | Buy | — | — | Reiterated | 2026-08-06 |
| — | UBS | Buy | — | — | Reiterated | 2026-07-08 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-05-18 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-05-13 |
| — | UBS | Buy | — | — | Reiterated | 2026-03-04 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-03-04 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-02-27 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-11-20 |
| — | Truist Securities | Buy | — | — | Reiterated | 2025-01-06 |
| — | Macquarie | Outperform | — | — | Reiterated | 2025-01-06 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2024-12-17 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2024-11-18 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-10-14 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-08-15 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2024-08-13 |
| — | Citigroup | Buy | — | — | Reiterated | 2024-08-13 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2024-08-13 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-07-15 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2024-05-15 |
| — | Truist Securities | Buy | — | — | Reiterated | 2024-05-15 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2024-05-15 |
| — | Stephens & Co. | Overweight | — | — | Reiterated | 2024-05-14 |
PACS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-02-26 | 0.48 | 0.43 | $1.38B | $1.36B |
| 2026-05-11 | 0.42 | 0.50 | $1.36B | $1.42B |
| 2026-08-04 | 0.54 | 0.63 | $1.41B | $1.43B |
| 2026-11-25 | 0.58 | 0.00 | $1.46B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.